Screening compound: C26H33N5O3 (L632-1230)

Screening compound: C<sub>26</sub>H<sub>33</sub>N<sub>5</sub>O<sub>3</sub> (L632-1230)
Screening compound: C<sub>26</sub>H<sub>33</sub>N<sub>5</sub>O<sub>3</sub> (L632-1230) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C26H33N5O3 (L632-1230)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L632-1230

Molecular Formula

C26H33N5O3 (C26 H33 N5 O3)

Compound Name

1-{5-cyclobutanecarbonyl-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3-carbonyl}-N-(2-methylphenyl)piperidine-3-carboxamide

IUPAC name

1-{5-cyclobutanecarbonyl-1-methyl-1H4H5H6H7H-pyrazolo[43-c]pyridine-3-carbonyl}-N-(2-methylphenyl)piperidine-3-carboxamide

SMILES

Cc(cccc1)c1NC(C(CCC1)CN1C(c1nn(C)c(CC2)c1CN2C(C1CCC1)=O)=O)=O

InChI

InChI=1S/C26H33N5O3/c1-17-7-3-4-11-21(17)27-24(32)19-10-6-13-30(15-19)26(34)23-20-16-31(25(33)18-8-5-9-18)14-12-22(20)29(2)28-23/h3-4,7,11,18-19H,5-6,8-10,12-16H2,1-2H3,(H,27,32)/t19-/m0/s1

InChI Key

FECOEOZITPUAHX-IBGZPJMESA-N

MDL Number (MFCD)

MFCD27466790

C26H33N5O3 (L632-1230) in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Proteases
  • Others
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Epigenetic
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with C26H33N5O3 (L632-1230) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C26H33N5O3 (L632-1230)?
Check Price and Availability of C26H33N5O3 (L632-1230), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C26H33N5O3 (L632-1230) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C26H33N5O3 (L632-1230)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C26H33N5O3 (L632-1230)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C26H33N5O3 (L632-1230) available by request